Is Design Therapeutics, Inc. (DSGN) a Buy, Sell, or Hold?
NASDAQ : DSGN
Design Therapeutics, Inc. — Competitors
$12.18 USD
-$0.44 (-3.49%)
- Volume
- 624.96K
- Average Volume
- 944.59K
- Market Capitalization
- $760.73M
- P/E Ratio
- -10.15
- Dividend Yield
- 0.00%
- Price Target
- $20.50
- Year High
- $17.25
- Year Low
- $3.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $22.28
DSGN vs. The Competition
| Properties | DSGN | ALT | ANNX | AURA |
|---|---|---|---|---|
| Market Cap | $760.73M | $250.65M | $834.78M | $450.04M |
| Shares Outstanding | $62.46M | $88.26M | $163.84M | $64.2M |
| P/E Ratio | -10.15 | -3.05 | -4.18 | -3.96 |
| EPS | -1.13 | -0.73 | -1.01 | -1.67 |
| Day Low | 12.05 | 2.78 | 5.025 | 6.845 |
| Day High | 12.635 | 2.99 | 5.4 | 7.055 |
| Year Low | 3.85 | 2.56 | 2.03 | 4.73 |
| Year High | 17.25 | 6.44 | 7.18 | 9.535 |
| Average Price 50 | 12.3409 | 2.888 | 5.3589 | 6.9636 |
| Average Price 200 | 10.62013 | 3.76368 | 5.1259 | 6.3732 |
| Volume | 624.96K | 3.79M | 2.73M | 290.57K |
| Average Volume | - | - | - | - |